TYPE 2 HEPATORENAL SYNDROME
Condition(s):Safety and Efficacy of Terlipressin and Noradrenaline and Predictive Factors of Response in Type 2 HRSLast Updated:July 11, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Safety and Efficacy of Terlipressin and Noradrenaline and Predictive Factors of Response in Type 2 HRSLast Updated:July 11, 2012Completed
Condition(s):Maternal HypotensionLast Updated:August 22, 2017Completed
Condition(s):Attention Deficit Disorder With Hyperactivity; Methylphenidate; PharmacogeneticsLast Updated:October 5, 2011Completed
Condition(s):Septic ShockLast Updated:November 29, 2018Unknown status
Condition(s):Hyperthermic Intraperitoneal Chemotherapy (HIPEC)Last Updated:May 13, 2022Completed
Condition(s):Haemorrhagic Shock; Variceal HemorrhageLast Updated:February 9, 2023Withdrawn
Condition(s):Comparing Ephedrine With Norepinephrine for Mangement Postspinal HypotensionLast Updated:August 30, 2022Completed
Condition(s):Control of Arterial Blood PressureLast Updated:October 3, 2016Completed
Condition(s):ShockLast Updated:February 1, 2010Completed
Condition(s):Vasoplegia SyndromeLast Updated:September 28, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.